Most people on Wegovy start noticing weight loss within the first month, but meaningful results take longer. In clinical trials, participants lost an average of about 15% of their body weight over 68 weeks (roughly 16 months). That means someone starting at 250 pounds could expect to lose around 37 pounds over that period, though individual results vary widely.
The timeline isn’t linear, though. Wegovy uses a slow dose-escalation schedule, so the first few months are designed more for your body to adjust than for dramatic weight loss. Here’s what to realistically expect at each stage.
The First 16 Weeks: Dose Escalation
Wegovy doesn’t start at its full dose. You begin at a low weekly injection and step up every four weeks across five stages:
- Weeks 1 to 4: 0.25 mg
- Weeks 5 to 8: 0.5 mg
- Weeks 9 to 12: 1 mg
- Weeks 13 to 16: 1.7 mg
- Week 17 onward: 2.4 mg (maintenance dose for adults)
This gradual ramp-up exists to reduce nausea and other digestive side effects. If you don’t tolerate a dose well, your prescriber may hold you at that level for an extra four weeks before moving up. The tradeoff is that you won’t reach the full therapeutic dose until roughly month five. Weight loss during the escalation phase is real but modest compared to what comes later.
How Wegovy Causes Weight Loss
Wegovy mimics a hormone called GLP-1 that your gut naturally releases after eating. This hormone signals your brain to reduce appetite and slows how quickly food leaves your stomach, so you feel full sooner and stay satisfied longer. The slowed stomach emptying is most pronounced in the first few weeks of treatment and partially fades by around week 16, but the appetite-suppressing effects in the brain persist.
In practical terms, most people find they simply want less food. Portions that once felt normal start to feel like too much. Cravings, especially for high-calorie foods, often decrease. This leads to a natural calorie reduction without the constant hunger that derails most diets.
Month-by-Month Weight Loss Pattern
Weight loss on Wegovy follows a fairly predictable curve. The first one to two months bring small but noticeable changes, typically a few pounds. As the dose increases through months three and four, the pace picks up. The steepest weight loss usually happens between months four and ten, once you’re on the full 2.4 mg maintenance dose and your body’s appetite signals have fully shifted.
By month six, many people have lost 10% or more of their starting weight. The large STEP 1 trial showed an average loss of about 15% of body weight at 68 weeks, compared to just 2.4% in the placebo group. That 12.5 percentage point difference is almost entirely attributable to the medication itself, not just the lifestyle counseling both groups received.
Somewhere between months six and twelve, weight loss typically slows and eventually levels off. This plateau isn’t a sign the medication stopped working. It reflects a new equilibrium: your body now burns fewer calories at a lower weight, and the calorie deficit that was driving loss has narrowed. Your metabolism adapts, your energy expenditure drops, and you settle at a new stable weight. For most people, this stabilization point represents a clinically significant amount of weight lost.
Results in Teenagers
Wegovy is also approved for adolescents aged 12 and older. In the STEP TEENS trial, participants aged 12 to 17 with obesity saw a 16.1% reduction in BMI and a 14.7% reduction in body weight over 68 weeks. The placebo group, by comparison, actually gained weight during the same period. The timeline and dose escalation schedule are similar to adults, though teens go directly to the 2.4 mg maintenance dose.
What Affects How Fast You Lose
Several factors influence where you fall on the weight loss spectrum. Starting weight matters: people with more to lose often see faster absolute losses early on. How well you tolerate the dose escalation plays a role too. If side effects force you to stay at a lower dose longer, the timeline stretches. Diet and activity level still matter, though the medication does a lot of the heavy lifting by controlling appetite.
Genetics also play a part. Some people are strong responders to GLP-1 medications and lose 20% or more of their body weight. Others may lose closer to 5 to 10%. There’s no reliable way to predict which category you’ll fall into before starting, but the first few months on the maintenance dose give a reasonable signal of your trajectory.
What Happens If You Stop
Weight regain after stopping Wegovy is common and well-documented. The medication works by changing your appetite signals, not by permanently resetting your metabolism. When those signals return to their pre-treatment state, hunger and cravings come back, and most people regain a significant portion of the weight they lost within a year of stopping. This is why Wegovy is generally considered a long-term or ongoing treatment rather than a short course.
If you’re evaluating whether Wegovy is worth starting, the realistic picture is this: expect gradual progress over four to five months of dose escalation, the most visible results between months five and twelve, and a plateau sometime after that. The average outcome in trials is a 15% total body weight reduction at about 16 months, with most of that loss happening in the middle stretch of treatment.